13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q3 2022. See the latest, Q2 2026 →
Reported value
$304.37B
−5.2% on the quarter before
Positions
429
31 new · 25 sold out
Top 10
28.0%
of the value
Est. gain
−$16.45B
on stocks held all quarter
Est. return
−5.4%
on those stocks since Q2 2022
Positions as of Sep 30, 2022, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 45% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2022. Striped tiles are options.
Largest buys
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Sea~$1.58BAdded · 0.1% → 0.6%+28,139,453 shares
- Abbvie Inc~$1.33BAdded · 1.3% → 1.6%+9,896,885 shares
- D R Horton Inc~$716.5MAdded · 0.2% → 0.4%+10,638,530 shares
- Eli Lilly~$597.8MAdded · 0.3% → 0.5%+1,848,662 shares
- Amazon~$538.9MAdded · 3.3% → 3.9%+4,769,416 shares
- Starbucks Corp~$476.3MAdded · 0.5% → 0.7%+5,653,226 shares
- Micron~$475.4MAdded · 0.7% → 0.8%+9,488,834 shares
- Broadcom~$455.0MAdded · 3.1% → 3.1%+1,024,647 shares
- Shopify Inc~$399.3MAdded · 0.4% → 0.5%+14,820,562 shares
- Stryker Corporation~$380.6MAdded · 0.7% → 0.8%+1,879,256 shares
Largest sells
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Eog Res Inc~$994.3MCut · 1.1% → 0.9%−8,899,220 shares
- Canadian Nat Res Ltd~$961.9MCut · 1.8% → 1.3%−20,664,738 shares
- Jpmorgan Chase & Co~$796.2MCut · 0.7% → 0.4%−7,618,792 shares
- Comcast Corp New~$585.3MCut · 1.7% → 1.1%−19,955,986 shares
- Linde Plc~$514.2MCut · 1.2% → 1.0%−1,907,403 shares
- Humana Inc~$510.2MCut · 0.6% → 0.5%−1,051,470 shares
- Tc Energy Corp~$508.5MCut · 0.7% → 0.4%−12,623,102 shares
- Csx Corp~$485.1MCut · 0.5% → 0.3%−18,210,194 shares
- Cenovus Energy Inc~$428.0MCut · 0.6% → 0.4%−27,860,739 shares
- Adobe~$378.5MCut · 0.2% → 0.0%−1,375,364 shares
Holdings
As of Sep 30, 2022. Changes are in shares against Jun 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −1.4% · price −9.3% | 6.4% | $19.36B | −$1.99B | ||||||||
| AmazonCOM · shares +4.8% · price +6.4% | 3.9% | $11.87B | +$680.9M | ||||||||
| Unitedhealth Group IncCOM · shares −2.7% · price −1.7% | 3.1% | $9.44B | −$160.6M | ||||||||
| BroadcomCOM · shares +5.1% · price −8.6% | 3.1% | $9.42B | −$843.6M | ||||||||
| Abbott LabsCOM · shares −1.6% · price −10.9% | 2.5% | $7.63B | −$937.0M | ||||||||
| Raytheon Technologies CorpCOM · shares +3.9% · price −14.8% | 2.1% | $6.37B | −$1.07B | ||||||||
| General Electric CoCOM NEW · shares +5.1% · price −2.8% | 1.9% | $5.64B | −$152.5M | ||||||||
| AppleCOM · shares +6.4% · price +1.1% | 1.7% | $5.31B | +$53.5M | ||||||||
| Philip Morris Intl IncCOM · shares −5.0% · price −15.9% | 1.7% | $5.24B | −$992.2M | ||||||||
| AlphabetCAP STK CL A · shares +2.8% · price −21.0% | 1.6% | $5.01B | −$1.30B | ||||||||
| Abbvie IncCOM · shares +38% · price −12.4% | 1.6% | $4.86B | −$498.3M | ||||||||
| AlphabetCAP STK CL C · shares +1.8% · price −16.5% | 1.5% | $4.70B | −$912.2M | ||||||||
| Thermo Fisher Scientific IncCOM · shares +0.1% · price −6.6% | 1.5% | $4.44B | −$315.4M | ||||||||
| MetaCL A · shares −3.0% · price −15.9% | 1.3% | $4.09B | −$771.0M | ||||||||
| Canadian Nat Res LtdCOM · shares −20% · price −13.4% | 1.3% | $3.95B | −$609.7M | ||||||||
| MastercardCL A · shares +4.5% · price −9.9% | 1.2% | $3.64B | −$381.0M | ||||||||
| NetflixCOM · shares +3.1% · price +34.6% | 1.2% | $3.61B | +$901.1M | ||||||||
| Comcast Corp NewCL A · shares −15% · price −25.3% | 1.1% | $3.38B | −$1.14B | ||||||||
| Gilead Sciences IncCOM · shares −3.8% · price −0.2% | 1.1% | $3.32B | −$6.5M | ||||||||
| Linde PlcSHS · shares −14% · price −6.2% | 1.0% | $3.19B | −$212.4M | ||||||||
| Carrier GlobalCOM · shares +5.4% · price −0.3% | 0.96% | $2.93B | −$7.8M | ||||||||
| Amgen IncCOM · shares −11% · price −7.4% | 0.93% | $2.84B | −$225.6M | ||||||||
| MercadoLibreCOM · shares +7.0% · price +30.0% | 0.88% | $2.68B | +$578.4M | ||||||||
| Eog Res IncCOM · shares −27% · price +1.2% | 0.86% | $2.63B | +$30.4M | ||||||||
| Baker HughesCL A · shares +13% · price −27.4% | 0.85% | $2.60B | −$866.2M | ||||||||
| Total · 429 positions | 100% | $304.37B | −$16.45B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2022 to Q3 2022: 395 stocks held throughout, down $16.45B (−5.4%).
- Netflix+$901.1M+35%
- Amazon+$680.9M+6%
- MercadoLibre+$578.4M+30%
- Wolfspeed+$543.9M+63%
- Pg&E Corp+$469.8M+25%
- Philip Morris Intl Inc−$992.2M−16%
- Raytheon Technologies Corp−$1.07B−15%
- Comcast Corp New−$1.14B−25%
- Alphabet18:1 split−$1.30B−21%
- Microsoft−$1.99B−9%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 4 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |